2014 Analysis of Leading Diagnostic Imaging Suppliers' Strategic Directions
US$ 2,000.00
This new report from Venture Planning Group provides strategic directions of global diagnostic imaging companies. The report presents insightful strategic assessments, including: Business, new product development, and marketing strategies. Anticipated acquisitions, joint ventures, and divestitures. The ...
November 2013
41 pages
2014 Analysis of the European HIV/AIDS Diagnostics Market: Hospitals, Blood Banks, Public Health Labs, Commercial Labs - Supplier Shares and Sales Forecasts For Immunodiagnostic and NAT Procedures
US$ 3,160.00
... DataPack (test volumes, sales forecasts, supplier shares) $2,500. Summary This 5-country report presents detailed analyses of the AIDS diagnostics market in Europe (France, Germany, Italy, Spain, UK). For each country, the report provides test volume and sales forecasts for HIV-1/2, HIV Ag, NAT, Western ...
November 2013
277 pages
2014 Analysis of the US Hepatitis Diagnostics Market: Hospitals, Blood Banks, Public Health Labs, Commercial Labs, Physician Offices - Supplier Shares and Sales Forecasts For 10 Immunodiagnostic and NAT Procedures
US$ 3,120.00
Complete report $3,900. DataPack (test volumes, sales forecasts, supplier shares) $2,500. The report presents a detailed analysis of the Hepatitis diagnostics market in the US. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test ...
November 2013
241 pages
2014 Analysis of the European Hepatitis Diagnostics Market: Hospitals, Blood Banks, Public Health Labs, Commercial Labs, Physician Offices - Supplier Shares and Sales Forecasts For 10 Immunodiagnostic and NAT Procedures
US$ 5,520.00
Complete report $6,900. DataPack (test volumes, sales forecasts, supplier shares) $4,500. The report presents a detailed analysis of the Hepatitis diagnostics market in Europe, (France, Germany, Italy, Spain, UK). Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. ...
November 2013
295 pages
2014 Analysis of the European Pap Smear/HPV Market
US$ 2,280.00
... . DataPack (test volumes, sales forecasts) $1,850. This report presents a detailed analysis of the Pap Smear/HPV testing market in Europe (France, Germany, Italy, Spain, UK), including clinical significance and current laboratory practice; as well as five-year test volume ...
November 2013
235 pages
2014 Analysis of the European Cell Surface Marker Testing Market: Hospitals, Commercial Labs, Ambulatory Care Centers
US$ 3,080.00
... $2,500. The report provides an overview of the cell surface marker testing in Europe (France, Germany, Italy, Spain, UK), including 5-year forecasts for CD4, CD8 ... and the analysis itself. This report presents a detailed overview of the CD4, CD8 and CD34 Cell Surface Marker testing in five European countries ...
November 2013
125 pages
2014 Analysis of the US Point-of-Care Infectious Disease Diagnostics Market: Physician Offices/Group Practices, Emergency Rooms, Ambulatory Care Centers, Surgery Centers, Birth Centers
US$ 4,400.00
... and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient. Market Segmentation Analysis Review of five POC market segments, including their dynamics, trends, structure, size, growth and major suppliers. Five-year test ...
November 2013
795 pages
2014 Analysis of the US Point-of-Care Hematology and Flow Cytometry Markets: Physician Offices, Emergency Rooms, Operating Suites, ICUs/CCUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers
US$ 4,400.00
... from hospitals and commercial laboratories closer to the patient. Market Segmentation Analysis Review of nine POC market segments, including their dynamics, trends, ... Centers Nursing Homes Birth Centers Sales and Market Share Analysis Sales and market shares of major hematology and flow cytometry ...
November 2013
238 pages
2014 Analysis of the US Point-of-Care Clinical Chemistry Market: Physician Offices, Emergency Rooms, Operating Suites, ICU/CCUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers
US$ 4,400.00
... from hospitals and commercial laboratories closer to the patient. Market Segmentation Analysis Review of nine POC market segments, including their dynamics, trends, ... Centers Nursing Homes Birth Centers Sales and Market Share Analysis Sales and market shares of major clinical chemistry reagent and ...
November 2013
373 pages
2014 Analysis of the US Point-of-Care Coagulation Testing Market: Physician Offices, Emergency Rooms, Operating Suites, ICU/CCUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers
US$ 4,400.00
... hospitals and commercial laboratories closer to the patient. Market Segmentation Analysis Review of nine POC market segments, including their dynamics, trends, ... Centers Nursing Homes Birth Centers Sales and Market Share Analysis Sales and market shares of major coagulation reagent and instrument ...
November 2013
418 pages
2014 Analysis of the US PT and APTT Point-of-Care Testing Market: Physician Offices, Emergency Rooms, Operating Suites, ICUs/CCUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers
US$ 2,320.00
... from hospitals and commercial laboratories closer to the patient. Market Segmentation Analysis Review of nine POC market segments, including their dynamics, trends ... Centers Nursing Homes Birth Centers Sales and Market Share Analysis Sales and market shares of major reagent and instrument suppliers ...
November 2013
337 pages
2014 Analysis of the UK Tumor Marker Testing Market: Innovations, Trends and Opportunities for Suppliers
US$ 4,880.00
Complete report $5,400. DataPack (test volumes, sales forecasts, supplier shares) $1,950. Highlights Comprehensive 575-page analysis of the UK tumor marker testing market. Major issues pertaining to the UK laboratory practice, as well as key economic, regulatory, demographic, social and technological ...
November 2013
575 pages
2014 Analysis of the US Tumor Marker Testing Market: Innovations, Trends and Opportunities for Suppliers
US$ 7,760.00
Complete report $8,700. DataPack (test volumes, sales forecasts, supplier shares) $3,450. Highlights Comprehensive 620-page analysis of the US tumor marker testing market. Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and technological ...
November 2013
620 pages
2014 Analysis of the Global Drugs of Abuse Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan
US$ 6,800.00
... (test volumes, sales forecasts, supplier shares) $5,500. This new 318-page report from Venture Planning Group contains 68 tables and provides analysis of the global drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic ...
November 2013
318 pages
2014 Analysis of the UK Drugs of Abuse Testing Market: Hospitals and Commercial Labs
US$ 1,960.00
This new 260-page report from Venture Planning Group provides a comprehensive analysis of the UK drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report provides test volume and sales ...
November 2013
260 pages
2014 Analysis of the European Drugs of Abuse Testing Market: Hospitals, Commercial Labs, Physician Offices, Ambulatory Care Centers
US$ 5,200.00
This new 300-page report from Venture Planning Group provides a comprehensive analysis of the European drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report provides test volume and sales ...
November 2013
300 pages
2014 Analysis of the Global Endocrine Function Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan
US$ 6,800.00
... (test volumes, sales forecasts, supplier shares) $5,500. This new 327-page report from Venture Planning Group contains 75 tables and provides analysis of the global endocrine function diagnostics market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares and ...
November 2013
327 pages